Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil painkillers to 15% from 22.

(Reuters) - Pfizer offloaded shares worth roughly $3.26 billion in Haleon at 380 pence apiece, cutting its stake to 15% in the world's largest standalone consumer healthcare firm, a bookrunner said on Tuesday.

The joint venture, Tianjin TSKF Pharmaceutical Co (TSKF), accounted for about 40% of Haleon's revenues from China last year, producing and distributing brands such as pain relief products Fenbid and Voltaren and wound ointment Bactroban.

Pfizer intends to sell about 540 million shares in British consumer healthcare company Haleon, a bookrunner said on Monday, reducing the top shareholder's interest in the Sensodyne maker to 16.2%. Haleon separately said on Monday it had agreed to make an off-market purchase of about 230 million pounds ($308.

Pfizer has sold a stake in British consumer healthcare group Haleon worth about $3.26 billion, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil painkillers to 15% from 22.